Published recall report · Foreign objectUpdated · 9 yr 9 mo ago
Hospira Inc., A Pfizer Company recall: Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
- Producer
- Hospira Inc., A Pfizer Company
- Brand
- BUPIVACAINE HYDROCHLORIDE
59064DK
- Dates on pack
- Lot # 59064DK, Exp. 11/17
More detail
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.